2nd Quarter - Report

TIBER CREEK GROUP for JAZZ PHARMACEUTICALS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to S. 3032 - the FDA STATES Act, and Health and Human Services pertaining to CBD policies.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
EMILY KIRLIN —
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3032 (117th)

Budget/Appropriations BUD

Appropriations issues related to the FDA enforcement of non-FDA approved CBD products; FY 2022 Agriculture, Food and Drug Administration Appropriations.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
EMILY KIRLIN —
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Issues related to the FDA and S. 3032 - the FDA STATES Act, and Health and Human Services pertaining to CBD policies.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
EMILY KIRLIN —
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3032 (117th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.